The Novel Spectrometry Platforms Market Size is valued at 12.85 Billion in 2022 and is predicted to reach 24.92 Billion by the year 2031 at a 8.00 % CAGR during the forecast period for 2023-2031.
Understanding the interaction at the molecular level requires spectrometry. Spectrometry, especially in the electromagnetic spectrum, is a crucial tool for researchers in astronomy, chemistry, materials science, and physics because it provides insight into the composition, physical structure, and electronic structure of matter on the atomic, molecular, macroscopic, and galactic scales. One such important field is biomedical spectroscopy, which is used for a variety of essential purposes like tissue analysis and medical imaging. Because these systems give off a lot of different wavelengths, it is possible to learn a lot about their structures, such as how the electrons are arranged in their ground and excited states.
It can also be used to measure biomolecules like corticosteroids, testosterone, aldosterone, etc., and also to analyse phytochemicals like glycosides, tannins, alkaloids, etc. It's also a part of the fermentation industry to keep the concentration of microbes and chemical substances stable. Mass spectrometry, which quantifies the mass-to-charge ratio of ions, is a significant example. It may be used to characterise a wide range of biomolecules, from sugars to proteins to oligonucleotides, and is hence an indispensable analytical tool in biological research.
Growth in the global market for Novel spectrometry platforms is anticipated throughout the forecast period, driven by the launch of new pharmaceuticals and the increasing willingness of businesses to invest in enhancing product quality. Providers of spectrometric services are also investing much in developing methods to integrate cutting-edge capabilities. Consequently, it is anticipated that the international market for Novel spectrometry will grow. Novel spectrometry's growing relevance outside of healthcare and the increasing number of companies eager to invest in biomedical research and manufacture inexpensive generic pharmaceuticals are all factors contributing to the market's growth. In 2022, Astrazeneca said that Big molecules and drug complexes that were previously too large to detect can now be mapped in tissue thanks to a recent development in mass spectrometry imaging. This technique can produce a greater comprehension of disease causes and therapeutic approaches with applications ranging from pharmacological efficacy to drug safety.
There are many issues with traditional spectrometers, such as the lack of automation in some systems, which lowers reproducibility and sensitivity. Novel spectrometers have emerged as a feasible choice after several issues with conventional spectrometers have been resolved. The high cost of spectrometry usage and a fundamental lack of awareness about the service's availability may be limiting factors for the industry.
Market Segmentation
The Novel Spectrometry Platforms market is segmented into two major categories: a type of Spectrometer and the end-user industry. The kind of spectrometer segment is classified into different devices Atomic Absorption Spectrometer, Mass Spectrometer, Near Infrared Spectrometer, Nuclear Magnetic Resonance Spectrometer, Raman Spectrometer and X-Ray Fluorescence Spectrometer. Another major segment end-user industry covers Agriculture / Pesticide Testing, Environmental Analysis, Food Biotechnology, Forensic Analysis, Pharmaceutical Analysis and other end users.
North America presently possesses the highest portion of the global market for Novel Spectrometry platforms because of improvements in healthcare infrastructure, rises in per capita income, and the existence of cutting-edge research institutions and laboratories.
Competitive Landscape
Some Major Key Players In The Novel Spectrometry Platforms Market:
- Agilent Technologies Inc.,
- Bruker,
- Danaher Corporation,
- JEOL Ltd.,
- Kore Technology Ltd.,
- Metrohm AG,
- LECO Corporation,
- PerkinElmer Inc.,
- Rigaku Corporation,
- Shimadzu Corporation,
- Thermo Fisher Scientific Inc.,
- Waters Corporation,
- Endress+Hauser Group,
- MKS Instruments, Inc.,
- FLIR Systems, Inc.,
- SCIEX,
- Analytik Jena,
- Rigaku Corporation,
- DANI Instruments,
- Advion, Inc.,
- AMETEK Process Instruments,
- Extrel CMS, LLC,
- MassTech Inc.,
- Hiden Analytical,
Novel Spectrometry Platforms Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2022 |
USD 12.85 Billion |
|
Revenue Forecast In 2031 |
USD 24.92 Billion |
|
Growth Rate CAGR |
CAGR of 8.00 % from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
Type of Spectrometers, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Agilent Technologies Inc., Bruker, Danaher Corporation, JEOL Ltd., Kore Technology Ltd., Metrohm AG, LECO Corporation, PerkinElmer Inc., Rigaku Corporation, Shimadzu Corporation, Thermo Fisher Scientific Inc., Waters Corporation, Endress+Hauser Group, MKS Instruments, Inc., FLIR Systems, Inc., SCIEX, Analytik Jena, Rigaku Corporation, DANI Instruments, Advion, Inc., AMETEK Process Instruments, Extrel CMS, LLC, MassTech Inc., Hiden Analytical, and other prominent players |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
